Deep Genomics has opened its doors. The University of Toronto spinout is working to explore the potential of applying deep learning to genomics, first as a way to improve genetic testing. The early focus on genetic testing is a way for Deep Genomics to get started quickly, but in the longer term the plan is to apply the approach to drug development and personalized medicine. "We envision a future where computers are trusted to predict the outcome of laboratory experiments and treatments, long before anyone picks up a test tube," Deep Genomics CEO Brendan Frey told Kurzweil Accelerating Intelligence. Article | More